Immupharma (IMM)

 

Latest News

ImmuPharma update on Lupuzor study

ImmuPharma, the specialist drug discovery and development company, has issued a further update on the progress of its p...

UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY

RNS Number: 7530J Immupharma PLC 14 September 2016 FOR IMMEDIATE RELEASE 14 SEPTEMBER 2016 ImmuPharma PLC ("ImmuPharma" or the "Company") UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY 11 US Sites Now Open 5 European Countries Now Recruiting ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and developm...

ImmuPharma to open new site in Lupuzor study

ImmuPharma has been asked to open a new site in Mauritius as part of the phase III clinical trial of Lupuzor, the group's l...

UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY

RNS Number: 1275J Immupharma PLC 07 September 2016 RNS: FOR IMMEDIATE RELEASE 7 SEPTEMBER 2016 ImmuPharma PLC ("ImmuPharma" or the "Company") UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY ImmuPharma Invited to Open an Additional Site in Mauritius Up to 30 Lupus patients ready for enrolment ImmuPharma PLC (LS...

All News

DateHeadlineSource
14-09-16ImmuPharma update on Lupuzor study StockMarketWire
14-09-16UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDYRNS
07-09-16ImmuPharma to open new site in Lupuzor study StockMarketWire
07-09-16UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDYRNS
21-07-16Holding(s) in CompanyRNS
20-07-16Broker Forecast - Northland Capital issues a broker note on ImmuPharma PLCStockMarketWire
01-07-16Holding(s) in CompanyRNS
27-06-16Second Price Monitoring ExtnRNS
27-06-16Price Monitoring ExtensionRNS
20-06-16ImmuPharma appoints joint broker StockMarketWire
20-06-16Appointment of Joint BrokerRNS
09-06-16Why are Immupharma plc, Purplebricks Group plc and Roxi Petroleum plc among today’s major movers?Motley Fool
09-06-16Holding(s) in CompanyRNS
08-06-16Symposium with Lupuzors Inventor Prof. S MullerRNS
07-06-16ImmuPharma update on Lupuzor studyStockMarketWire
07-06-16Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?Motley Fool
07-06-16European Patients Commence Dosing in LupuzorRNS
02-06-16Director/PDMR ShareholdingRNS
31-05-16Holding(s) in CompanyRNS
26-05-16ImmuPharma resolutions passed at AGMStockMarketWire
26-05-16Result of AGMRNS
25-05-16Holding(s) in CompanyRNS
04-05-16ImmuPharma losses widenStockMarketWire
04-05-16Annual Financial Report & Notice of AGMRNS
04-05-16Final ResultsRNS
26-04-16ImmuPharma schedules FY results StockMarketWire
26-04-16Notice of ResultsRNS
22-04-16Holding(s) in CompanyRNS
09-03-16ImmuPharma starts European patient recruitment for Lupuzor trial StockMarketWire
09-03-16First European Site Opens - Patient RecruitmentRNS
08-03-16Holding(s) in CompanyRNS
07-03-16Holding(s) in CompanyRNS
01-03-16EIS and VCT Qualifying Status and Issue of EquityRNS
29-02-16Holding(s) in CompanyRNS
24-02-16ImmuPharma raises GBP7.7mStockMarketWire
24-02-16Issue of EquityRNS
22-02-16ImmuPharma fundraising approved StockMarketWire
22-02-16Result of GMRNS
15-02-16Dosing starts for ImmuPharma's Lupuzor trial StockMarketWire
15-02-16US PATIENTS COMMENCE DOSING IN PHASE III STUDYRNS

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory